Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1631 1632 1634 1657
This examiner grants 65% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18483917 | Therapeutic Supernatant from Cell-Seeded Substrates and Related Methods | Non-Final OA | The Regents of the University of California |
| 18311459 | SPATIALLY CONTROLLED FABRICATION OF MULTI-SPHEROID TISSUES USING MAGNETIC BIOPRINTING | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 17907122 | SUPPORTING BATH FOR THREE-DIMENSIONAL (3D) TISSUE CULTURE | Non-Final OA | OSAKA UNIVERSITY |
| 18559925 | METHODS FOR DELIVERING GENOME EDITING MOLECULES TO THE NUCLEUS OR CYTOSOL OF A CELL AND USES THEREOF | Non-Final OA | STEMCELL TECHNOLOGIES CANADA INC. |
| 18256801 | NOVEL HUMAN ERYTHROID PROGENITOR CELL LINE HIGHLY PERMISSIVE TO B19 INFECTION AND USES THEREOF | Non-Final OA | LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES |
| 18383601 | Extracranial Methods For Facilitating Cerebrospinal Fluid Drainage | Non-Final OA | Korea Advanced Institute of Science & Technology |
| 18490773 | ENGINEERED MITOCHONDRIA AND PREPARATION METHOD THEREOF | Non-Final OA | CHONGQING UNIVERSITY OF TECHNOLOGY |
| 18482493 | METHODS OF MODULATING CELL PHENOTYPE BY WAY OF REGULATING THE GASEOUS ENVIRONMENT | Non-Final OA | XCELL BIOSCIENCES, INC. |
| 18029863 | ORGANOID RECOMBINATION | Non-Final OA | CHILDREN'S HOSPITAL MEDICAL CENTER |
| 18342896 | SELECTION AND USE OF UMBILICAL CORD CELL FRACTIONS SUITABLE FOR TRANSPLANTATION | Non-Final OA | Gamida Cell Ltd |
| 18036815 | SECRETOME FRACTIONS AND USES THEREOF | Non-Final OA | NOVEOME BIOTHERAPEUTICS, INC. |
| 17623250 | COMPOSITION AND METHOD FOR RENDERING BIOLOGICAL MATERIAL | Non-Final OA | JELLOX BIOTECH INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy